Picture of Opthea logo

OPT Opthea News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousMicro CapTurnaround

Brief: Opthea Data For Opt-302 In Combination With Ranibizumab For Polypoidal Choroidal Vasculopathy (Pcv) Presented At Arvo 2022

May 5 (Reuters) - Opthea Ltd  OPT.AX :
    * OPTHEA DATA FOR OPT-302 IN COMBINATION WITH RANIBIZUMAB
FOR
POLYPOIDAL CHOROIDAL VASCULOPATHY (PCV) PRESENTED AT ARVO 2022

Source text for Eikon:  ID:nGNX4cQ2jW 
Further company coverage:  OPT.AX 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Opthea

See all news